本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR
Ridgeback Capital Investments L.P. (CIK 1423994) reported $80.9M across 1 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: REPL ($80.9M, 100.00%), PYXS ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | REPL | Replimune Group Inc. | $80.9M | 100.00% | 7.3M | New |
| 2 | PYXS | Pyxis Oncology Inc | $0 | 0.00% | 0 | Exited |
来源：SEC 13F 申报文件 · 截至 2026-06-30